Dr. Jie-Bin Lew is a researcher of Gastrointestinal Cancers Group. Her research focuses on optimising colorectal cancer screening subgroup in Australia and other countries. Jie-Bin led the development of a comprehensive microsimulation model of colorectal cancer natural history and screening in Australia (Policy1-Bowel). This model has been applied to several evaluations on important bowel cancer screening policy questions in Australia. Findings from these evaluations were used to support colorectal cancer screening guidelines recommendations and government funding decision in Australia.
- Doctor of Philosophy, UNSW
- Master of Public Health, The University of Sydney
- Bachelor of Science (Bioinformatics), The University of Sydney
- Lew JB. (2019-2020) Bupa Health Foundation Emerging Health Researcher Award (Finalist)
- Shi JF and Lew JB (Jan 2020-Dec 2024). Evaluation of Benefits and Cost-effectiveness of a Newly Applied Colorectal Cancer Screening Strategy in a National Public Health Program in China.
- Lew JB. (2021-2025) NHMRC Investigator Grant (EL1) APP1194784. Optimising colorectal cancer screening in high-income countries and low- and middle-income countries using Australia and China as an example.
Honorary Research Fellow, Sydney School of Public Health, The University of Sydney
Current student supervision
Selected key publications
- Lew JB, St John DJB, Xu XM, et al. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. Lancet Public Health. 2017;2(7):e331-e340.
- Lew JB, St John DJB, Macrae FA, et al. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia. Cancer Epidemiol Biomarkers Prev. 2018;27(12):1450-1461.
- Lew JB, St John DJB, Macrae FA, et al. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia. Int J Cancer. 2018;143(2):269-282.
- Worthington J, Feletto E, Lew JB, et al. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia. Public Health. 2020;179:90-99.
- Lew JB, Simms KT, Smith MA, et al. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. Lancet Public Health. 2017;2(2):e96-e107.